Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yikang Lu

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos One|January 11, 2023
Assessing the medical resources in COVID-19 based on evolutionary gameKeyu Guo, Yikang Lu, Yini Geng, et al.
Chaos (Woodbury, N.Y.)|September 1, 2022
Enhancing coexistence of mobile species in the cyclic competition system by wildlife refugeYikang Lu, Chen Shen, Mengjie Wu, et al.
Chaos (Woodbury, N.Y.)|July 6, 2023
Reinforcement learning relieves the vaccination dilemmaYikang Lu, Yanan Wang, Yifan Liu, et al.
Chaos (Woodbury, N.Y.)|January 8, 2026
Fitness-driven adaptive competition as a double-edged mechanism in maintaining biodiversity under cyclic competitionHuangming Lv, Yunxiang Hou, Hui Dai, et al.
Chaos (Woodbury, N.Y.)|April 4, 2024
Replicator-mutator dynamics with evolutionary public goods game-environmental feedbacksChunpeng Du, Yikang Lu, Yali Zhang, et al.
Physical Review. E|January 21, 2026
Higher-order processes shape diverse patterns in biodiversityYikang Lu, Rong Fan, Yali Zhang, et al.
Physical Review. E|February 17, 2024
Understanding the role of neutral species by means of high-order interaction in the rock-paper-scissors dynamicsYikang Lu, Xiaoyue Wang, Chunpeng Du, et al.
Trials|September 10, 2020
A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trialShaoying Yang, Ruoning Ni, Yikang Lu, et al.
Cell Division|October 10, 2024
MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4/MyD88 signalingYandong Lv, Shuwei Guo, Lingtong Jin, et al.
Rheumatology (Oxford, England)|December 13, 2024
Increased risk of malignancy and osteoporosis in primary Sjögren's syndrome with thyroid diseases: potential implication from T cellsXiaomeng Cui, Jun Li, Yizhen Sang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|January 11, 2023
Assessing the medical resources in COVID-19 based on evolutionary gameKeyu Guo, Yikang Lu, Yini Geng, et al.
Chaos (Woodbury, N.Y.)|September 1, 2022
Enhancing coexistence of mobile species in the cyclic competition system by wildlife refugeYikang Lu, Chen Shen, Mengjie Wu, et al.
Chaos (Woodbury, N.Y.)|July 6, 2023
Reinforcement learning relieves the vaccination dilemmaYikang Lu, Yanan Wang, Yifan Liu, et al.
Chaos (Woodbury, N.Y.)|January 8, 2026
Fitness-driven adaptive competition as a double-edged mechanism in maintaining biodiversity under cyclic competitionHuangming Lv, Yunxiang Hou, Hui Dai, et al.
Chaos (Woodbury, N.Y.)|April 4, 2024
Replicator-mutator dynamics with evolutionary public goods game-environmental feedbacksChunpeng Du, Yikang Lu, Yali Zhang, et al.
Physical Review. E|January 21, 2026
Higher-order processes shape diverse patterns in biodiversityYikang Lu, Rong Fan, Yali Zhang, et al.
Physical Review. E|February 17, 2024
Understanding the role of neutral species by means of high-order interaction in the rock-paper-scissors dynamicsYikang Lu, Xiaoyue Wang, Chunpeng Du, et al.
Trials|September 10, 2020
A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trialShaoying Yang, Ruoning Ni, Yikang Lu, et al.
Cell Division|October 10, 2024
MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4/MyD88 signalingYandong Lv, Shuwei Guo, Lingtong Jin, et al.
Rheumatology (Oxford, England)|December 13, 2024
Increased risk of malignancy and osteoporosis in primary Sjögren's syndrome with thyroid diseases: potential implication from T cellsXiaomeng Cui, Jun Li, Yizhen Sang, et al.
Pageof 3